NANOENCAPSULATED RUTIN ENHANCES TESTICULAR ANTIOXIDANT DEFENSE AND STEROIDOGENIC GENE EXPRESSION IN DRUG-INDUCED REPRODUCTIVE TOXICITY

Husam Atiya Kadhim

doi:10.70604/jmtbas.v3i2.200

Authors

Husam Atiya Kadhim Ministry of Education, General Directorate of Al-Qadisiyah Education, Diwaniyah 58001, Iraq

Abstract

Doxorubicin (DOX) is a widely used anthracycline anticancer agent, yet its clinical utility is limited by considerable off-target damage that also extends to the male reproductive tract. Rutin is a naturally occurring flavonol glycoside with well-recognized antioxidant activity; however its poor aqueous solubility and rapid first-pass metabolism limit its in vivo performance. In the present work, rutin was loaded into chitosan-coated poly(lactic-co-glycolic acid) (PLGA) nanoparticles (NE-RUT) and its protective effect against DOX-induced testicular toxicity was evaluated in adult male Wistar rats. Forty animals were randomly distributed into four groups (n = 8): control, DOX (3 mg/kg i.p. on days 1, 4, 7, 10), DOX plus free rutin (50 mg/kg p.o.), and DOX plus NE-RUT (equivalent rutin dose, p.o.) for 28 days. Testicular tissue was processed for biochemical analysis, real-time PCR of steroidogenic genes, and sperm parameter assessment. NE-RUT exhibited a mean hydrodynamic diameter of 142 ± 8 nm, polydispersity index of 0.18, zeta potential of −28.4 mV, and an entrapment efficiency of 86.2%. Compared with the DOX group, NE-RUT significantly restored testicular SOD, CAT and GPx activities, lowered MDA, replenished GSH, and brought serum testosterone close to control values. Importantly, NE-RUT upregulated the mRNA expression of StAR, CYP11A1, 3β-HSD, and 17β-HSD to nearly control levels and outperformed free rutin across all endpoints. Sperm count, motility, viability, and normal morphology were also markedly improved. Collectively, the data suggest that nanoencapsulation considerably enhances the protective potential of rutin and may serve as a promising adjunct strategy in chemotherapy-associated reproductive injury.

Keywords:

Doxorubicin, Rutin, Nanoencapsulation, PLGA-chitosan, Testicular toxicity, Steroidogenesis

DOI

https://doi.org/10.70604/jmtbas.v3i2.200

References

1. Carvalho FS, Burgeiro A, Garcia R, Moreno AJ, Carvalho RA, Oliveira PJ. Doxorubicin-induced cardiotoxicity: from bioenergetic failure and cell death to cardiomyopathy. Med Res Rev. 2014;34(1):106–135.

2. Singal PK, Iliskovic N. Doxorubicin-induced cardiomyopathy. N Engl J Med. 1998;339(13):900–905.

3. Atessahin A, Turk G, Karahan I, Yilmaz S, Ceribasi AO, Bulmus O. Lycopene prevents adriamycin-induced testicular toxicity in rats. Fertil Steril. 2006;85(Suppl 1):1216–1222.

4. Hou M, Chrysis D, Nurmio M, Parvinen M, Eksborg S, Söder O, et al. Doxorubicin induces apoptosis in germ-line stem cells in the immature rat testis. Toxicol Appl Pharmacol. 2005;205(3):237–243.

5. Aitken RJ, Roman SD. Antioxidant systems and oxidative stress in the testes. Oxid Med Cell Longev. 2008;1(1):15–24.

6. Ganeshpurkar A, Saluja AK. The pharmacological potential of rutin. Saudi Pharm J. 2017;25(2):149–164.

7. Hosseinzadeh H, Nassiri-Asl M. Review of the protective effects of rutin on the metabolic function as an important dietary flavonoid. J Endocrinol Invest. 2014;37(9):783–788.

8. Çelik H, Kucukler S, Çomaklı S, Caglayan C, Özdemir S, Yardım A, et al. Rutin attenuates oxidative stress and inflammation in acrylamide-induced reproductive toxicity in rats. Food Chem Toxicol. 2020;144:111595.

9. Caglayan C, Temel Y, Kandemir FM, Yildirim S, Kucukler S. Rutin protects against cisplatin-induced testicular damage by modulating oxidative stress, apoptosis and inflammation. Andrologia. 2021;53(8):e14096.

10. Pandey RP, Parajuli P, Koffas MAG, Sohng JK. Microbial production of natural and non-natural flavonoids: pathway engineering, directed evolution and systems/synthetic biology. Biotechnol Adv. 2016;34(5):634–662.

11. Yang J, Yang Z, Wang Y, Liu Y, Wang H, Ji L, et al. Preparation and evaluation of rutin-loaded chitosan/poly(D,L-lactic-co-glycolic acid) nanoparticles for oral delivery. Int J Pharm. 2018;542(1–2):234–245.

12. Mignet N, Seguin J, Chabot GG. Bioavailability of polyphenol liposomes: a challenge ahead of us. Int J Nanomedicine. 2012;7:5095–5106.

13. Pandey M, Choudhury H, Gunasegaran TAP, Nathan SS, Md S, Gorain B, et al. Hyaluronic acid-modified betamethasone encapsulated polymeric nanoparticles: fabrication, characterisation, in vitro release kinetics, and dermal targeting. Drug Deliv. 2020;27(1):234–245.

14. Khan MA, Tania M, Zhang D, Chen H. Antioxidant enzymes and cancer. Chin J Cancer Res. 2019;22(2):87–92.

15. Calvo P, Remuñán-López C, Vila-Jato JL, Alonso MJ. Chitosan and chitosan/ethylene oxide-propylene oxide block copolymer nanoparticles as novel carriers for proteins and vaccines. Pharm Res. 1997;14(10):1431–1436.

16. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. J Control Release. 2012;161(2):505–522.

17. Stocco DM. StAR protein and the regulation of steroid hormone biosynthesis. Annu Rev Physiol. 2001;63:193–213.

18. Payne AH, Hales DB. Overview of steroidogenic enzymes in the pathway from cholesterol to active steroid hormones. Endocr Rev. 2004;25(6):947–970.

19. Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev. 2011;32(1):81–151.

20. Aksu EH, Kandemir FM, Özkaraca M, Ömür AD, Küçükler S, Çomaklı S. Rutin ameliorates cisplatin-induced reproductive damage via suppression of oxidative stress and apoptosis in adult male rats. Andrologia. 2017;49(9):e12760.

21. Trivedi PP, Tripathi DN, Jena GB. Hesperetin and rutin alleviate γ-radiation induced oxidative damage and germ cell apoptosis in male reproductive system of mice. Reprod Toxicol. 2019;85:38–47.

22. Sharma S, Ali A, Ali J, Sahni JK, Baboota S. Rutin: therapeutic potential and recent advances in drug delivery. Expert Opin Investig Drugs. 2013;22(8):1063–1079.

23. Seed J, Chapin RE, Clegg ED, Dostal LA, Foote RH, Hurtt ME, et al. Methods for assessing sperm motility, morphology, and counts in the rat, rabbit, and dog: a consensus report. Reprod Toxicol. 1996;10(3):237–244.

24. Wyrobek AJ, Gordon LA, Burkhart JG, Francis MW, Kapp RW Jr, Letz G, et al. An evaluation of the mouse sperm morphology test and other sperm tests in non-human mammals. Mutat Res. 1983;115(1):1–72.

25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408.

26. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121–126.

27. Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem. 1974;47(3):469–474.

28. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med. 1967;70(1):158–169.

29. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351–358.

30. Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys. 1959;82(1):70–77.